Shanghai, China – May 31, 2017 — Asieris Pharmaceuticals, a clinical stage biopharmaceutical company, announced today that the company presented at the ChinaBio® Partnering Forum, a premier life science partnering conference in China, held on May 31 – June 1, 2017, in Zhuhai International Convention & Exhibition Center. The event attracted more than 800 biotech and pharma leaders, investors, and consultants from 300 companies and 30 countries, making it the largest partnering conference of its kind in China.
Asieris Pharmaceuticals was honored to have presented a roadshow at this forum. Ms. Dandan Xie, Senior Business Development Manager of Asieris, showcased the company’s recent rapid development and its leading candidate drug APL-1202, and expressed the company’s strong intent for global partnership. The audience were impressed by Asieris’ capability in urogenital therapeutic areas. Shortly after the Forum, Asieris has held potential partnership discussions with a number of leading domestic and overseas pharma companies and research institutions.
